Clarifying how government- and sponsor-paid experts can sometimes aid sponsors in meetings with FDA, the agency updated its Manual of Policies and Procedures (MAPP) concerning special government employees (SGEs) who represent sponsors before the agency’s Center for Drug Evaluation and Research (CDER).
Source: Drug Industry Daily